Bank of New York Mellon’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Sell |
243,327
-85,846
| -26% | -$1.49M | ﹤0.01% | 2366 |
|
|
2025
Q1 | $7.2M | Sell |
329,173
-5,243
| -2% | -$115K | ﹤0.01% | 2018 |
|
|
2024
Q4 | $10.7M | Sell |
334,416
-9,323
| -3% | -$297K | ﹤0.01% | 1886 |
|
|
2024
Q3 | $9.91M | Sell |
343,739
-1,456
| -0.4% | -$42K | ﹤0.01% | 1936 |
|
|
2024
Q2 | $13.2M | Buy |
345,195
+22,273
| +7% | +$854K | ﹤0.01% | 1812 |
|
|
2024
Q1 | $19M | Sell |
322,922
-49,333
| -13% | -$2.9M | ﹤0.01% | 1606 |
|
|
2023
Q4 | $22.3M | Buy |
372,255
+11,968
| +3% | +$716K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $13.7M | Buy |
360,287
+2,998
| +0.8% | +$114K | ﹤0.01% | 1762 |
|
|
2023
Q2 | $32.5M | Sell |
357,289
-35,107
| -9% | -$3.2M | 0.01% | 1264 |
|
|
2023
Q1 | $25.9M | Sell |
392,396
-12,643
| -3% | -$834K | 0.01% | 1412 |
|
|
2022
Q4 | $20.9M | Sell |
405,039
-3,420
| -0.8% | -$177K | ﹤0.01% | 1516 |
|
|
2022
Q3 | $27.9M | Buy |
408,459
+60,309
| +17% | +$4.12M | 0.01% | 1295 |
|
|
2022
Q2 | $15.7M | Buy |
348,150
+32,670
| +10% | +$1.48M | ﹤0.01% | 1679 |
|
|
2022
Q1 | $16M | Buy |
315,480
+17,287
| +6% | +$878K | ﹤0.01% | 1803 |
|
|
2021
Q4 | $14.1M | Buy |
298,193
+28,709
| +11% | +$1.36M | ﹤0.01% | 1914 |
|
|
2021
Q3 | $8.88M | Buy |
269,484
+7,456
| +3% | +$246K | ﹤0.01% | 2192 |
|
|
2021
Q2 | $16.6M | Buy |
262,028
+34,894
| +15% | +$2.21M | ﹤0.01% | 1844 |
|
|
2021
Q1 | $9.75M | Sell |
227,134
-27,073
| -11% | -$1.16M | ﹤0.01% | 2098 |
|
|
2020
Q4 | $14.5M | Buy |
254,207
+15,847
| +7% | +$906K | ﹤0.01% | 1807 |
|
|
2020
Q3 | $7.19M | Sell |
238,360
-5,280
| -2% | -$159K | ﹤0.01% | 2034 |
|
|
2020
Q2 | $7.96M | Buy |
243,640
+3,621
| +2% | +$118K | ﹤0.01% | 1966 |
|
|
2020
Q1 | $6.43M | Buy |
240,019
+43,820
| +22% | +$1.17M | ﹤0.01% | 1946 |
|
|
2019
Q4 | $6.01M | Buy |
196,199
+6,073
| +3% | +$186K | ﹤0.01% | 2241 |
|
|
2019
Q3 | $4.58M | Sell |
190,126
-9,931
| -5% | -$239K | ﹤0.01% | 2324 |
|
|
2019
Q2 | $5.07M | Buy |
200,057
+30,405
| +18% | +$770K | ﹤0.01% | 2326 |
|
|
2019
Q1 | $3.31M | Buy |
169,652
+16,932
| +11% | +$330K | ﹤0.01% | 2525 |
|
|
2018
Q4 | $2.02M | Buy |
152,720
+9,932
| +7% | +$131K | ﹤0.01% | 2717 |
|
|
2018
Q3 | $2.54M | Buy |
142,788
+15,621
| +12% | +$278K | ﹤0.01% | 2719 |
|
|
2018
Q2 | $2.8M | Buy |
127,167
+92,280
| +265% | +$2.03M | ﹤0.01% | 2665 |
|
|
2018
Q1 | $771K | Buy |
34,887
+15,721
| +82% | +$347K | ﹤0.01% | 3342 |
|
|
2017
Q4 | $416K | Buy |
+19,166
| New | +$416K | ﹤0.01% | 3673 |
|